AbbVie
ABBV
ABBV
2,973 hedge funds and large institutions have $161B invested in AbbVie in 2021 Q4 according to their latest regulatory filings, with 455 funds opening new positions, 1,277 increasing their positions, 916 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
27% more capital invested
Capital invested by funds: $127B → $161B (+$33.8B)
12% more funds holding
Funds holding: 2,647 → 2,973 (+326)
0.73% more ownership
Funds ownership: 66.64% → 67.37% (+0.73%)
Holders
2,973
Holding in Top 10
214
Calls
$4.17B
Puts
$3.15B
Top Buyers
| 1 | +$753M | |
| 2 | +$384M | |
| 3 | +$315M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$307M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$226M |
Top Sellers
| 1 | -$1.34B | |
| 2 | -$538M | |
| 3 | -$311M | |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$298M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$212M |